Haemophilia Survey Finds Persistently Low Quality of Life in Northeast China
Adults living with haemophilia in Northeast China reported strikingly poor health-related quality of life, with daily functioning, economic strain and joint damage emerging as central burdens in a cross-sectional survey published in BMJ Open. The findings place a clinical value on issues that extend far beyond bleeding episodes alone: pain, mobility limits, work disruption and the burden of treatment costs all appear to shape how patients experience the disease.
The study enrolled adults aged 18 years or older with mild, moderate or severe haemophilia and used self-completed questionnaires to capture sociodemographic characteristics, target joint status and health-related quality of life measured with the EQ-5D-5L. The instrument produced a mean utility score of 0.51 with a standard deviation of 0.34, a level that signals substantial impairment in perceived health status. In practical terms, this is not a narrow laboratory signal or a bleeding count on paper. It is a patient-reported picture of illness that touches movement, comfort, anxiety, self-care and usual activities.
Severe Disease, Target Joints and Financial Strain Shape Patient Experience
Participants with severe haemophilia had a lower mean utility score than those with mild or moderate disease, 0.46±0.37 versus 0.56±0.30, although the comparison did not reach statistical significance in this sample (p=0.737). Even without a significant between-group difference, the direction of the effect fits the biology of the disorder. Recurrent bleeding into joints and soft tissues can accumulate into chronic arthropathy, stiffness and pain, and those sequelae are difficult to capture fully with severity labels alone.
The regression analysis identified several factors linked to lower EQ-5D utility scores. Older age above 25 years, having two or more target joints, not working, low knowledge of the disease and borrowing money to pay for medical treatment were all associated with worse reported quality of life. A single patient living with one damaged joint may manage a limited set of daily constraints; multiple target joints change the equation. When bleeding history, disability and financial pressure intersect, the burden becomes both physical and social.
One result stands out for its direct bedside relevance: borrowing money to pay for treatment tracked with worse quality of life. For a chronic hereditary bleeding disorder, treatment access is part of the disease experience, not a separate social issue.
Why Joint Damage and Age Matter So Much
The clinical pattern is easy to understand. Haemophilia is not only a deficiency of coagulation factors; it is also a condition in which repeated haemarthroses can produce a cycle of synovial inflammation, cartilage injury and progressive loss of function. Once a patient develops target joints, the disease becomes harder to ignore in daily life. Walking, climbing stairs, working, sleeping and participating in family roles all may be affected.
Older age likely captures more than years alone. It may reflect longer cumulative exposure to bleeding, more established joint disease and the gradual social consequences of living with a chronic condition. In younger adults, the burden may be masked by compensation and adaptation. With time, those strategies often fail to keep up with pain, mobility loss and reduced employment prospects.
The employment finding deserves equal attention. Not working was associated with poorer quality of life, and the relationship probably runs in both directions. Severe joint disease can make physical labor difficult, but unemployment or underemployment can also reduce access to care, intensify financial stress and erode social participation. For patients with haemophilia, work is not merely an economic outcome. It is often a marker of functional independence.
Disease Knowledge Appears to Be a Modifiable Lever
Low disease knowledge was also associated with worse scores, which points toward an opportunity for education and self-management support. Patients who understand bleeding risk, joint protection, treatment timing and warning signs may navigate the disease with more confidence. They may also be better positioned to seek care early, adhere to prophylaxis or on-demand treatment plans and avoid preventable joint injury.
That educational gap is important because haemophilia care depends on repeated decisions made outside the clinic. Patients and families must recognize bleeding episodes, judge severity, know when replacement therapy is needed and decide when symptoms require urgent evaluation. In a condition where disease burden builds over years, those decisions can shape long-term function.
The survey design does have limits. It was cross-sectional, so the associations cannot prove causation. Snowball sampling can also introduce selection bias, and the sample likely reflects the patients who were reachable through social networks rather than a fully representative regional population. The study also relied on self-reported data, which may not perfectly capture severity, joint status or resource constraints. Even so, the pattern is clinically coherent and difficult to dismiss.
Social Support Extends Beyond Bleeding Control
The most important message from this survey is that haemophilia management should not stop at haemostatic control. The disease affects education, work, finances, mobility and the ability to participate in ordinary life. Patients with multiple target joints or financial barriers may need more intensive support than standard treatment plans alone can provide.
Clinical teams managing haemophilia may need to think more broadly about pain control, rehabilitation, employment support, patient education and assistance with treatment access. Those elements are not ancillary. They are part of the pathway that determines whether a patient can live with the disorder rather than be constrained by it.
This survey from Northeast China adds regional evidence to a familiar clinical reality: in haemophilia, bleeding risk and joint disease drive only part of the burden. Quality of life falls when mobility, knowledge and financial security fall with it, and those pressures can persist well beyond the acute bleed itself.